Skip to content
The Nexus
DossierENTITY

Cumberland Pharmaceuticals Inc.

Coverage of Cumberland Pharmaceuticals Inc. in the Nexus archive.

Earliest in view: Aug 4 · 21:19 UTCMost recent: Aug 4 · 21:19 UTC
Co-mentioned in this coverage
Nashville, Tenn.place1Automated Insightsorganization1Zacks Investment Researchorganization1CPIXorganization1
Recent coverage
  • BUSINESSAug 4 · 21:19 UTCWTOP DC
    Cumberland: Q2 Earnings Snapshot

    Cumberland Pharmaceuticals Inc. reported a second-quarter loss of $4.1 million, or 27 cents per share, with adjusted losses at 20 cents per share and revenue of $166,000.

Cumberland Pharmaceuticals Inc. · Dossier · The Nexus